🇺🇸 FDA

Intelligence · Patent portfolio

Eton Pharmaceuticals Patents

Full USPTO pharma patent portfolio for Eton Pharmaceuticals — grant dates, expiration, and drug cross-links.

Patents
163
Expiring ≤24m
6

Quick answer

Eton Pharmaceuticals has 163 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 6 expire within 24 months — use filters for patent-cliff planning.

Page 1 of 4

  1. US 12419831

    Hydrocortisone oral liquid formulations

    Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12396974

    Ketone ester as a therapeutic treatment of Covid-19 and related viral infections

    Expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12357582

    Hydrophobic ion pairing and flash nanoprecipitation for formation of controlled-release nanocarrier formulations

    Expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12343324

    Dihydromyricetin hot melt extrusion formulations and methods for forming them

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12329816

    Immunotherapy with metabolic enzyme expression

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12209256

    System for protein inactivation and recombinant phages for targeted bacterial killing, infection, biodetection, and as a means of protein extraction

    Expires Mon Jan 23 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12195768

    System and method for modulating stress granule assembly

    Expires Mon Jan 09 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12186436

    Triblock copolymer stabilizers for the formation of nanoparticles encapsulating soluble biologics, therapeutics, and imaging agents

    Expires Mon Jan 02 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12162855

    Tetrahydroquinolino derivatives for the treatment of metastatic and chemoresistant cancers

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12133914

    Hydrocortisone oral liquid formulations

    Expires Mon Oct 31 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 12083230

    Nano-encapsulation using GRAS materials and applications thereof

    Expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 12054475

    Substituted heterocycles as aldehyde dehydrogenase inhibitors

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11939402

    Antifungal peptides, compounds including the same, and methods of use thereof

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11904046

    Hydrocortisone oral liquid formulations

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11859234

    Method of monitoring RNase L activity

    Expires Mon Dec 28 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11814625

    Aptamers as a therapeutic tool to prevent protein aggregation in neurodegenerative disease

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11813235

    Guanfacine as an anti-virulence agent

    Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11759453

    SHMT inhibitors

    Expires Mon Sep 14 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 11737981

    Cellulosic polymer nanoparticles and methods of forming them

    Expires Mon Aug 24 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11731099

    Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation

    Expires Mon Aug 17 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 11629174

    Cryptic metabolites and method for activating silent biosynthetic gene clusters in actinomycete bacteria

    Expires Mon Apr 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 11554101

    Process for encapsulating soluble biologics, therapeutics, and imaging agents

    Expires Mon Jan 12 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 11549950

    Cryptic metabolites and method for activating silent biosynthetic gene clusters in diverse microorganisms

    Expires Mon Jan 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 11486802

    Methods and devices for high throughput purification

    Expires Mon Oct 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 11376225

    Composite flash-precipitated nanoparticles

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 11369588

    NADPH production by the 10-formyl-THF pathway, and its use in the diagnosis and treatment of disease

    Expires Mon Jun 23 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 11312756

    Engineered potent cytotoxic stapled BH3 peptides

    Expires Mon Apr 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 11306288

    Methods for preparing therapeutically active cells using microfluidics

    Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 11266611

    More potent and less toxic formulations of epinephrine and methods of medical use

    Expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 11147784

    Dietary supplements and composition for treating cancer

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 11149251

    Methods for preparing therapeutically active cells using microfluidics

    Expires Mon Oct 14 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 11142746

    High efficiency microfluidic purification of stem cells to improve transplants

    Expires Mon Oct 07 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 11129891

    Cytomegalovirus surface protein complex for use in vaccines and as a drug target

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 11103461

    Process for encapsulating soluble biologics, therapeutics, and imaging agents

    Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 11077109

    Compounds having antibacterial activity and methods of use

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 11008551

    Method to increase the infectivity of virus particles

    Expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 10988734

    Methods for preparing therapeutically active cells using microfluidics

    Expires Mon Apr 22 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 10980990

    Systems, devices, and/or methods for managing transdermal patches

    Expires Mon Apr 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 10974235

    Targeted, metal-catalyzed fluorination of complex compounds with fluoride ion via decarboxylation

    Expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 10940119

    Nano-encapsulation using GRAS materials and applications thereof

    Expires Mon Mar 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 10934305

    SHMT inhibitors

    Expires Mon Feb 25 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 10905775

    Particulate constructs for release of active agents

    Expires Mon Jan 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 10883980

    Methods and compositions for inhibiting hepatitis E virus

    Expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 10864266

    Modified lipopolysaccharide glycoform and method of use

    Expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 10852220

    Methods and devices for high throughput purification

    Expires Mon Nov 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 10842980

    Systems, devices, and/or methods for managing transdermal patches

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 10844353

    Methods for preparing therapeutically active cells using microfluidics

    Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 10813934

    Sirtuin modulators as inhibitors of cytomegalovirus

    Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Eton Pharmaceuticals have?

163 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Eton Pharmaceuticals patents expire?

6 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.